First Aid Research Recalls Maximum Strength Bacitraycin Plus Ointment With Lidocaine Due to Failure to Meet Child Resistant Closure Requirement

What was recalled

In early March of 2018, the U.S. Consumer Product Safety Commission (CPSC) announced a voluntary recall involving a specific batch of over-the-counter first aid products manufactured by First Aid Research. This action centered on their "Maximum Strength Bacitraycin Plus Ointment with Lidocaine." While this product is commonly used for minor cuts, scrapes, and burns to prevent infection and relieve pain, the specific units involved in this recall were found to have a critical packaging defect that rendered them unsafe for households with young children. The recall was officially initiated on March 7, 2018, marking the date when consumers were formally notified to stop using these particular items.

The product in question is distinguished by its specific physical characteristics and labeling, which can help you identify if your tube is part of this affected group. It comes packaged in a white, one-ounce tube that measures approximately five inches in length and one inch in width. The front of the tube prominently displays the words "Bacitraycin Plus" printed in green lettering. On the back of the packaging, you will find the list of active ingredients, which includes lidocaine along with bacitracin zinc. It is important to note that while the product itself functions as intended for its medical purpose, the issue lies entirely in how it is sealed and protected, not in the chemical composition of the ointment.

The scope of this recall is defined strictly by lot numbers printed on the end of each tube. Not every batch of this ointment was affected; only those produced during specific timeframes were included. If your product does not have one of the following lot numbers, it is not part of this recall: Lot Numbers 16001 through 16002; 404001 through 404002; 405001 through 405003; 406001 through 406004; 407001 through 407002; 415001 through 415010; 416001 through 416003; and 417001 through 417004. The recall was driven by the importer, United Exchange, in coordination with First Aid Research. Although the CPSC does not always disclose every retail outlet where a product is sold, these items were distributed widely enough to warrant a broad consumer alert due to the nature of the hazard.

The reason this specific batch requires such urgent attention is rooted in federal safety standards. The Poison Prevention Packaging Act mandates that certain hazardous household substances be packaged in child-resistant containers to prevent accidental ingestion or exposure by children under five years old. In this case, the packaging used for these tubes failed to meet those rigorous closure requirements. This means that a child could potentially open the tube with relative ease, exposing themselves to lidocaine, a local anesthetic that can be toxic if ingested or absorbed through the skin in large amounts. Consequently, even though there were no reported incidents of poisoning at the time of the recall, the potential for harm was significant enough to trigger this corrective action.

The hazard, explained

At the heart of this recall is a straightforward but dangerous oversight: the packaging for the Maximum Strength Bacitraycin Plus Ointment with Lidocaine does not meet the federal standards for child-resistant closure. Under the Poison Prevention Packaging Act (PPPA), consumer products that contain hazardous substances must be packaged in special containers that are difficult for young children to open, yet easy for adults to use. This requirement exists because standard caps or twist-tops can be manipulated by curious toddlers who have developed the dexterity to unscrew lids but lack the judgment to understand what they are handling. In this specific case, the ointment tubes provided do not possess those necessary protective barriers, meaning any child with enough grip strength and persistence can access the contents.

The risk is compounded by the active ingredients inside the tube. This product contains lidocaine, a local anesthetic that works by blocking nerve signals in the body to prevent pain from reaching the brain. While effective for adults treating minor cuts or burns, lidocaine is significantly more potent and dangerous for small children. Because toddlers have less body mass and their metabolic systems are still developing, even a small amount of medication can lead to toxic levels in their bloodstream. The hazard here is twofold: first, the child gains physical access to the tube due to the inadequate packaging; second, they are exposed to a chemical that can cause serious systemic poisoning.

Poisoning from topical lidocaine products typically occurs through ingestion or excessive absorption through the skin. If a child puts the ointment in their mouth, they may experience nausea, vomiting, dizziness, or seizures. If the medication is applied to large areas of skin or absorbed rapidly, it can interfere with the heart's electrical activity, leading to irregular heartbeats or even cardiac arrest. This is not a matter of minor upset stomach; it is a medical emergency that requires immediate attention. The fact that no incidents have been reported so far is fortunate, but it does not reduce the severity of the potential outcome. The hazard is real and present in every unit sold with the affected lot numbers, regardless of whether a child has already tried to open one.

It is important to understand that this is not a defect in the ointment itself—the medication inside is likely safe when used correctly by an adult. The failure lies entirely in the delivery system. The tube’s design allows for unauthorized access, turning a standard household first-aid item into a potential source of accidental poisoning. By removing these specific lots from circulation, the Consumer Product Safety Commission (CPSC) and First Aid Research are addressing the root cause: the inability of the packaging to serve its primary safety function of keeping dangerous substances out of reach of young children.

Who is most at risk

While this recall affects anyone who purchased the specific lots of First Aid Research’s Maximum Strength Bacitraycin Plus Ointment with Lidocaine, the primary individuals at serious risk are young children, particularly those under the age of five. The core issue driving this safety alert is not a chemical defect in the ointment itself, but rather the failure of the packaging to meet federal child-resistant closure standards. For households with curious toddlers or infants who explore their environment by putting objects in their mouths, the absence of a secure, difficult-to-open cap transforms a standard first-aid item into a potential hazard. Children are naturally drawn to bright colors, interesting textures, and sweet tastes; while this ointment is not flavored, its accessibility means that a child can easily unscrew or pull open the tube if it is stored in an accessible location like a bathroom cabinet, bedside table, or kitchen counter.

The vulnerability of young children stems from their physiological development. Their bodies are significantly smaller than adults, meaning that a dose of medication considered safe for an adult can be toxic to a child. The recalled ointment contains lidocaine, a local anesthetic that numbs pain and itching. When ingested or absorbed through the skin in large quantities by a small body, lidocaine can lead to poisoning. Symptoms of lidocaine toxicity in children may include dizziness, confusion, seizures, difficulty breathing, or changes in heart rate. Because infants and toddlers cannot articulate their symptoms clearly, parents might miss early signs of distress, allowing the condition to worsen before help is sought. This makes prevention through proper storage absolutely critical.

Elderly individuals or those with cognitive impairments also fall into a higher-risk category for different reasons. While they may not ingest the product accidentally like a toddler, they might mistakenly apply it without realizing the packaging does not seal properly, leading to contamination of the ointment or accidental spills that could be ingested if hands are not washed thoroughly. Furthermore, individuals with sensitive skin or known allergies to bacitracin or lidocaine should avoid use entirely, though this is a general precaution for any topical medication rather than a specific result of this recall. The risk here is compounded by the fact that the product was sold as "Maximum Strength," implying a higher concentration of active ingredients that requires careful handling.

Finally, pet owners should be aware that while not explicitly listed in the incident reports, many household medications are toxic to animals if ingested. Cats and dogs may lick tubes left open or dropped on the floor, leading to unexpected veterinary emergencies. Therefore, the "at-risk" group extends beyond human family members to include any pets that roam freely in areas where first-aid supplies are kept. The lack of a child-resistant seal means there is no barrier to prevent access by any curious mouth, whether human or animal.

• Young Children: Highest risk due to natural curiosity and inability to understand danger signs; small body mass makes even small doses toxic.
• Elderly/Cognitively Impaired: Risk of accidental ingestion due to confusion or improper handling of non-sealed containers.
• Pets: Potential for accidental ingestion if tubes are left open or dropped, leading to veterinary emergencies.

How to tell if you have the recalled item

Before you take any action, the most critical step is to verify exactly what you have in your medicine cabinet. The Consumer Product Safety Commission (CPSC) has identified a very specific batch of Maximum Strength Bacitraycin Plus Ointment with Lidocaine manufactured by First Aid Research that requires immediate attention. Because these products can look similar to other first aid supplies on the shelf, it is important to check every detail carefully. Do not rely solely on the brand name or the general purpose of the tube; you must examine the physical container and its printed information to confirm if it falls within the recall scope.

Start by looking at the packaging itself. The recalled ointment comes in a white, one-ounce tube. On the front of this tube, you should see the words "Bacitraycin Plus" printed clearly in green lettering. This is a key visual identifier that distinguishes it from other versions or competitors. If your tube is a different color, such as blue or clear, or if the text on the front is not green, it is likely not part of this specific recall, but always double-check the back for ingredient lists to be sure.

Once you have identified the correct looking tube, turn it over to read the label details. The back of the tube will list the active ingredients, and you must confirm that Lidocaine is listed as one of the two active ingredients. This confirms it is the pain-relieving version affected by the issue. Next, look at the dimensions of the tube itself. The recalled items measure approximately 5 inches in length by 1 inch in width. If your tube feels significantly smaller or larger than this standard size, it may not be included.

The most definitive way to confirm if your product is subject to this recall is to check the lot number printed on the end of the tube. The CPSC has specified a wide range of lot numbers that are included in this recall action. Your item is affected if its lot number falls within any of the following ranges: 16001 through 16002; 404001 through 404002; 405001 through 405003; 406001 through 406004; 407001 through 407002; 415001 through 415010; 416001 through 416003; or 417001 through 417004. If you are unsure about the lot number or cannot find it, please contact United Exchange for assistance.

• Brand: First Aid Research
• Product Name: Maximum Strength Bacitraycin Plus Ointment with Lidocaine
• Packaging: White, one-ounce tube with green text on the front
• Dimensions: Approximately 5 inches long by 1 inch wide
• Lot Numbers to Check: 16001-16002, 404001-404002, 405001-405003, 406001-406004, 407001-407002, 415001-415010, 416001-416003, 417001-417004

If your product matches these descriptions and falls within the listed lot number ranges, please stop using it immediately and follow the remedy instructions provided by the importer. If you do not see a lot number or are unable to determine if your item is affected, err on the side of caution and contact United Exchange directly for clarification.

What to do — step by step

If you have any of the recalled Maximum Strength Bacitraycin Plus Ointment with Lidocaine in your home, the most important thing you can do right now is to act calmly but decisively. The U.S. Consumer Product Safety Commission (CPSC) and First Aid Research have identified a specific safety gap: the packaging does not meet the required child-resistant standards under the Poison Prevention Packaging Act. This means that curious young children can open the tube easily, leading to potential poisoning from the lidocaine inside. Please follow these concrete steps to protect your family and resolve the issue.

1. Stop using the product immediately. Even if the ointment is still full or unopened, do not apply it to anyone. The primary danger is not the medicine itself when used correctly, but the inability of the packaging to keep children from accessing it. Place the tube in a secure location that is completely out of sight and reach of any child, such as a locked cabinet or a high shelf that toddlers cannot climb to.
2. Check your lot numbers carefully. The recall applies only to specific batches of the product. Look at the end of the white one-ounce tube for the printed lot number. The affected lots include 16001 through 16002, 404001 through 404002, 405001 through 405003, 406001 through 406004, 407001 through 407002, 415001 through 415010, 416001 through 416003, and 417001 through 417004. If your lot number falls within these ranges, the item is definitely part of this recall.
3. Contact United Exchange for instructions. United Exchange is the importer responsible for handling this recall. You should reach out to them directly to initiate the return process. Call their toll-free line at 888-645-8204. Their customer service team is available from 8 a.m. to 5 p.m. Pacific Time, Monday through Friday. Alternatively, you can visit their website at www.firstaidresearch.com and click on the “Recall” section for online assistance.
4. Request a full refund. When you contact United Exchange, inform them that you have one of the recalled tubes. They will provide specific instructions on how to return the product or dispose of it safely. In this case, the remedy provided is a full refund from your place of purchase. Keep your receipt handy if possible, as it may help streamline the process with the store where you bought the ointment.
5. Dispose of the product safely after receiving guidance. Do not simply throw the tube in the regular trash without checking with the manufacturer or retailer first. They may want the item back to ensure it does not re-enter the market, or they may have specific disposal instructions to prevent accidental exposure. Once you have followed their advice, you are free to purchase a different brand of first aid ointment that has proper child-resistant packaging.

Taking these steps ensures that your family remains safe while you get your money back. It is better to be cautious with over-the-counter medications, especially those containing numbing agents like lidocaine, which can be harmful if ingested or absorbed in large amounts by small children.

Your refund, repair, or replacement options

When a product is recalled due to a safety failure, it is natural to feel frustrated, especially if you were relying on that item for peace of mind during a minor medical emergency. However, the recall process is designed to remove the risk entirely and make you whole financially. In this specific instance involving First Aid Research’s Maximum Strength Bacitraycin Plus Ointment with Lidocaine, the remedy is straightforward: there is no repair option available, nor is there a replacement product offered by the manufacturer. Instead, the official remedy is a full refund. This approach makes logical sense given the nature of the defect. The issue lies with the packaging’s failure to meet child-resistant closure requirements mandated by the Poison Prevention Packaging Act. Because the safety mechanism itself—the cap—is defective and cannot be easily swapped out or fixed without compromising the seal, the only viable solution is to return the entire product for a refund.

To initiate this process, you must contact United Exchange, the importer of record for these products. They are handling the logistics of the recall on behalf of First Aid Research. You have two primary methods for reaching them. The most direct way is to call their toll-free customer service line at 888-645-8204. It is important to note their operating hours; they are available from 8 a.m. to 5 p.m. Pacific Time, Monday through Friday. If you happen to be in a different time zone or prefer written communication, you can visit their website at www.firstaidresearch.com. On the homepage, look for and click on the “Recall” link to find detailed instructions and potentially an online form for processing your claim.

Before you make contact, gather your recalled item and locate the lot number printed on the end of the tube. The recall specifically targets lots numbered 16001 through 16002, 404001 through 404002, 405001 through 405003, 406001 through 406004, 407001 through 407002, 415001 through 415010, 416001 through 416003, and 417001 through 417004. Having this information ready will speed up the verification process. While the instructions from United Exchange will guide you on whether you need to mail the product back or if you can simply keep it for safe disposal, the financial remedy is guaranteed: you will receive a full refund from the place of purchase. This ensures that your safety concern does not result in an out-of-pocket loss. Please act promptly to secure this refund and ensure the defective ointment is kept far away from any children in your home.

What can happen if you ignore it

It is completely understandable why you might hesitate to part with a tube of ointment sitting in your bathroom cabinet. It looks harmless enough, it has likely been sitting there for months or even years, and the idea of throwing away medicine that hasn’t even been opened can feel like a waste. However, ignoring this recall is not just about losing a few dollars; it is about leaving a specific chemical hazard accessible to the most vulnerable members of your household. The core issue here is not that the ointment itself is dangerous when used correctly, but that its packaging fails to perform the critical safety function it was designed to do: keeping young children from accessing it.

The primary risk stems from the presence of lidocaine, a local anesthetic that numbs pain. While lidocaine is effective and widely used in medicine for adults and older children under supervision, it poses a significant poisoning risk to toddlers and infants. If a child manages to open the non-compliant tube because it lacks the required child-resistant closure, they may ingest the ointment or apply it to their skin without any adult oversight. Children’s bodies are much smaller than adults’, meaning that even a small amount of lidocaine can lead to toxic levels in their system. Ingestion can cause serious symptoms including nausea, vomiting, dizziness, and in severe cases, seizures or heart rhythm disturbances. This is not a hypothetical scenario based on speculation; it is the specific reason the Consumer Product Safety Commission (CPSC) intervened. Although no incidents have been reported to date for this specific lot of First Aid Research products, the absence of reported injuries does not mean the risk is low—it simply means that, so far, the children in these homes have either not found the tubes or have been lucky.

Furthermore, ignoring the recall keeps the product within reach during moments when supervision might be fleeting. A parent might step away for just a second to answer the phone or check on another child, and that is all it takes for a curious toddler to discover the bright white tube with green lettering. Because the packaging does not meet the Poison Prevention Packaging Act standards, it offers no meaningful barrier to determination. By continuing to keep this product in your home, you are essentially gambling with your child’s safety against a known mechanical failure of the container. The ointment may still be effective for treating minor cuts or scrapes on adults, but its value is completely outweighed by the danger it presents if accessed by a young child. The potential consequences of ignoring this warning are not just theoretical; they are medical emergencies that could have been entirely prevented by following the recall instructions.

There is also the broader issue of false security. When we keep recalled items around, we inadvertently normalize the presence of unsafe products in our homes. We might tell ourselves, "I’ll just put it on a high shelf," but toddlers are remarkably adept at climbing and reaching. Relying on your own vigilance to compensate for a defective product is a fragile safety net. If the tube falls, rolls under furniture, or is placed on a lower surface during a routine cleaning, the risk spikes immediately. Ignoring the recall means you are maintaining a hazard that requires constant, perfect attention to manage, whereas removing it eliminates the hazard entirely.

Ultimately, the consequence of inaction is that you remain exposed to a preventable poisoning event. The ointment contains Bacitraycin Plus and Lidocaine, and while these ingredients are standard for first aid, their combination in an easily openable package creates a perfect storm for accidental exposure. You are not just keeping a tube of cream; you are keeping a potential source of acute toxicity within arm's reach of someone who cannot understand the danger. The peace of mind that comes from knowing your child cannot accidentally access this product is worth far more than the cost of the ointment itself.

Staying safe: broader tips

While this specific recall highlights the importance of child-resistant packaging for topical medications, the underlying principle extends to how we manage all household hazards. The most effective way to prevent accidental poisoning or injury is to create layers of protection that account for human error. First and foremost, always store medications and chemicals in their original containers with the caps fully secured. Many caregivers mistakenly transfer pills into daily organizers or assume that a standard twist cap provides sufficient safety. However, children are remarkably persistent and clever; they can often manipulate simple closures that seem secure to adults. Therefore, relying solely on the packaging mechanism is risky. Instead, treat every medication as a potential hazard until it is securely stored in a high, locked cabinet or a dedicated lockbox that is completely inaccessible to young hands.

Beyond storage habits, regular awareness of product safety updates is a critical part of responsible home management. Products are recalled for various reasons, from manufacturing defects to labeling errors, and these updates happen frequently. Rather than waiting for a crisis, make it a habit to periodically check the Consumer Product Safety Commission (CPSC) website or sign up for their email alerts. This proactive approach ensures that you are informed about potential issues before they become dangerous. It is also wise to register your products with the manufacturer when possible. Registration allows companies to contact you directly if a safety issue arises, ensuring you do not miss critical warnings buried in general news reports.

Additionally, consider the broader context of your home’s safety environment. If you have young children or elderly family members who may be more vulnerable to chemical exposure, establish clear rules about where items can and cannot be placed. Never leave medications on nightstands, kitchen counters, or in purses that are within easy reach. These "temporary" spots are often the first places a curious child will explore. By keeping all potentially harmful substances out of sight and out of reach, you remove the temptation and opportunity for accidents. This simple strategy, combined with regular checks of your inventory against recall lists, creates a robust safety net that protects your family from both known and unforeseen risks.

• Keep all medications in high, locked cabinets away from children’s view and reach.
• Register products with manufacturers to receive direct notifications about safety issues.
• Regularly check the CPSC website for updates on recalls relevant to your household items.